{"name":"Red Abbey Venture Partners","permalink":"red-abbey-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/red-abbey-venture-partners","homepage_url":"http://www.redabbey.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"(410) 494-7401","description":"","email_address":"mzuga@redabbey.com","number_of_employees":null,"founded_year":2004,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jun 04 06:22:14 UTC 2009","updated_at":"Thu Jun 04 06:27:29 UTC 2009","overview":"<p>Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies. </p>","image":{"available_sizes":[[[150,98],"assets/images/resized/0004/6604/46604v1-max-150x150.jpg"],[[175,115],"assets/images/resized/0004/6604/46604v1-max-250x250.jpg"],[[175,115],"assets/images/resized/0004/6604/46604v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":" 2330 West Joppa Road","address2":"Suite 330","zip_code":"21093","city":"Baltimore","state_code":"MD","country_code":"USA","latitude":39.418504,"longitude":-76.668268}],"relationships":[{"is_past":false,"title":"Managing Director","person":{"first_name":"Matt","last_name":"Zuga","permalink":"matt-zuga","image":null}}],"investments":[{"funding_round":{"round_code":"b","source_url":"","source_description":"Capital Funding Report","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":21,"company":{"name":"Stromedix","permalink":"stromedix","image":{"available_sizes":[[[150,58],"assets/images/resized/0004/6603/46603v1-max-150x150.png"],[[195,76],"assets/images/resized/0004/6603/46603v1-max-250x250.png"],[[195,76],"assets/images/resized/0004/6603/46603v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"angel","source_url":"http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_23/ai_n30930200/?tag=content;col1","source_description":"Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License","raised_amount":2300000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":23,"company":{"name":"Arginetix","permalink":"arginetx","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9307/49307v1-max-150x150.png"],[[250,67],"assets/images/resized/0004/9307/49307v1-max-250x250.png"],[[450,122],"assets/images/resized/0004/9307/49307v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/arginetix-inc-series-b-46m/","source_description":"Arginetix, Inc.: Series B $4.6M","raised_amount":4600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":2,"company":{"name":"Arginetix","permalink":"arginetx","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9307/49307v1-max-150x150.png"],[[250,67],"assets/images/resized/0004/9307/49307v1-max-250x250.png"],[[450,122],"assets/images/resized/0004/9307/49307v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oxagen-rounds-26-7m-vc/2009-11-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oxagen rounds up $26.7M in VC","raised_amount":26700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":24,"company":{"name":"Oxagen","permalink":"oxagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/7578/67578v1-max-150x150.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-250x250.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://abh.com/press_releases/pr_022707.html","source_description":"Advanced BioHealing Raises $25.5 Million in Series C Financing","raised_amount":25500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":2,"funded_day":27,"company":{"name":"Advanced BioHealing","permalink":"advanced-biohealing","image":{"available_sizes":[[[150,62],"assets/images/resized/0008/0074/80074v1-max-150x150.jpg"],[[238,99],"assets/images/resized/0008/0074/80074v1-max-250x250.jpg"],[[238,99],"assets/images/resized/0008/0074/80074v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://macrogenics.com/press_releases-244.html","source_description":"MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":17,"company":{"name":"MacroGenics","permalink":"macrogenics","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/9708/59708v1-max-150x150.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-250x250.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://anacor.com/press_release_2005-05-11a.php","source_description":"ANACOR PHARMACEUTICALS RAISES $25 MILLION IN SERIES C FINANCING","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":11,"company":{"name":"Anacor Pharmaceutical","permalink":"anacor-pharmaceutical","image":{"available_sizes":[[[150,50],"assets/images/resized/0004/9566/49566v1-max-150x150.png"],[[171,57],"assets/images/resized/0004/9566/49566v1-max-250x250.png"],[[171,57],"assets/images/resized/0004/9566/49566v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/Arginetix-and-Immune-Control-bw-1922954142.html?x=0&.v=1","source_description":"Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Corridor Pharmaceuticals","permalink":"corridor-pharmaceuticals","image":null}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}